Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-27

FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)

View source ↗

Summary

FDA approved a supplemental application for Narcan nasal naloxone from Emergent Devices Inc., approving an addition to the already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NARCAN (Naloxone hydrochloride nasal)

Snippet

SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)